Nonfatal Suicidal Overdose of Olanzapine in an Adolescent

Lokesh Kumar Singh, Samir Kumar Praharaj, Manoj Sahu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The atypical antipsychotic olanzapine is increasingly being used for various psychiatric conditions. There are few reports of olanzapine overdose in adolescent population. We report a case of 16-year-old adolescent who ingested 750 mg olanzapine, the highest reported nonlethal dose of olanzapine in adolescents. He presented with tachycardia, hypotension, generalized myoclonus, hyperpyrexia, muscular rigidity, leukocytosis and elevated creatine phosphokinase (CPK) levels. He recovered from the toxicity with minimal intervention.

Original languageEnglish
Pages (from-to)328-329
Number of pages2
JournalCurrent Drug Safety
Volume7
Issue number4
DOIs
Publication statusPublished - 01-12-2012

Fingerprint

olanzapine
Muscle Rigidity
Myoclonus
Leukocytosis
Creatine Kinase
Tachycardia
Rigidity
Hypotension
Antipsychotic Agents
Psychiatry
Toxicity
Population

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Toxicology
  • Pharmacology

Cite this

Singh, Lokesh Kumar ; Praharaj, Samir Kumar ; Sahu, Manoj. / Nonfatal Suicidal Overdose of Olanzapine in an Adolescent. In: Current Drug Safety. 2012 ; Vol. 7, No. 4. pp. 328-329.
@article{9ef0cd10b4d7486f93670089179f83e3,
title = "Nonfatal Suicidal Overdose of Olanzapine in an Adolescent",
abstract = "The atypical antipsychotic olanzapine is increasingly being used for various psychiatric conditions. There are few reports of olanzapine overdose in adolescent population. We report a case of 16-year-old adolescent who ingested 750 mg olanzapine, the highest reported nonlethal dose of olanzapine in adolescents. He presented with tachycardia, hypotension, generalized myoclonus, hyperpyrexia, muscular rigidity, leukocytosis and elevated creatine phosphokinase (CPK) levels. He recovered from the toxicity with minimal intervention.",
author = "Singh, {Lokesh Kumar} and Praharaj, {Samir Kumar} and Manoj Sahu",
year = "2012",
month = "12",
day = "1",
doi = "10.2174/157488612804096605",
language = "English",
volume = "7",
pages = "328--329",
journal = "Current Drug Safety",
issn = "1574-8863",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

Nonfatal Suicidal Overdose of Olanzapine in an Adolescent. / Singh, Lokesh Kumar; Praharaj, Samir Kumar; Sahu, Manoj.

In: Current Drug Safety, Vol. 7, No. 4, 01.12.2012, p. 328-329.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nonfatal Suicidal Overdose of Olanzapine in an Adolescent

AU - Singh, Lokesh Kumar

AU - Praharaj, Samir Kumar

AU - Sahu, Manoj

PY - 2012/12/1

Y1 - 2012/12/1

N2 - The atypical antipsychotic olanzapine is increasingly being used for various psychiatric conditions. There are few reports of olanzapine overdose in adolescent population. We report a case of 16-year-old adolescent who ingested 750 mg olanzapine, the highest reported nonlethal dose of olanzapine in adolescents. He presented with tachycardia, hypotension, generalized myoclonus, hyperpyrexia, muscular rigidity, leukocytosis and elevated creatine phosphokinase (CPK) levels. He recovered from the toxicity with minimal intervention.

AB - The atypical antipsychotic olanzapine is increasingly being used for various psychiatric conditions. There are few reports of olanzapine overdose in adolescent population. We report a case of 16-year-old adolescent who ingested 750 mg olanzapine, the highest reported nonlethal dose of olanzapine in adolescents. He presented with tachycardia, hypotension, generalized myoclonus, hyperpyrexia, muscular rigidity, leukocytosis and elevated creatine phosphokinase (CPK) levels. He recovered from the toxicity with minimal intervention.

UR - http://www.scopus.com/inward/record.url?scp=84876722037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876722037&partnerID=8YFLogxK

U2 - 10.2174/157488612804096605

DO - 10.2174/157488612804096605

M3 - Article

C2 - 23062245

AN - SCOPUS:84876722037

VL - 7

SP - 328

EP - 329

JO - Current Drug Safety

JF - Current Drug Safety

SN - 1574-8863

IS - 4

ER -